- Home
- SNDL vs HUMA Comparison
SNDL vs HUMA Comparison
Compare SNDL & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDL
- HUMA
- Stock Information
- Founded
- SNDL 2006
- HUMA 2004
- Country
- SNDL Canada
- HUMA United States
- Employees
- SNDL N/A
- HUMA N/A
- Industry
- SNDL Pharmaceuticals and Biotechnology
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- SNDL Health Care
- HUMA Health Care
- Exchange
- SNDL Nasdaq
- HUMA Nasdaq
- Market Cap
- SNDL 651.1M
- HUMA 250.2M
- IPO Year
- SNDL 2019
- HUMA N/A
- Fundamental
- Price
- SNDL $2.68
- HUMA $1.51
- Analyst Decision
- SNDL
- HUMA Strong Buy
- Analyst Count
- SNDL 0
- HUMA 8
- Target Price
- SNDL N/A
- HUMA $10.88
- AVG Volume (30 Days)
- SNDL 4.8M
- HUMA 5.9M
- Earning Date
- SNDL 07-31-2025
- HUMA 08-11-2025
- Dividend Yield
- SNDL N/A
- HUMA N/A
- EPS Growth
- SNDL N/A
- HUMA N/A
- EPS
- SNDL N/A
- HUMA N/A
- Revenue
- SNDL $692,339,389.00
- HUMA $818,000.00
- Revenue This Year
- SNDL $5.52
- HUMA N/A
- Revenue Next Year
- SNDL $4.09
- HUMA $949.92
- P/E Ratio
- SNDL N/A
- HUMA N/A
- Revenue Growth
- SNDL 3.54
- HUMA N/A
- 52 Week Low
- SNDL $1.15
- HUMA $1.15
- 52 Week High
- SNDL $2.74
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- SNDL 82.41
- HUMA 36.87
- Support Level
- SNDL $2.07
- HUMA $1.43
- Resistance Level
- SNDL $2.74
- HUMA $1.67
- Average True Range (ATR)
- SNDL 0.14
- HUMA 0.15
- MACD
- SNDL 0.05
- HUMA -0.01
- Stochastic Oscillator
- SNDL 92.50
- HUMA 23.32
About SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.